POEMS syndrome other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{Sab}} | {{CMG}}{{AE}}{{Sab}} | ||
==Overview== | ==Overview== | ||
(18)F-FDG [[Positron emission tomography|PET]]/[[Computed tomography|CT]] is an adequate tool for evaluation, [[diagnosis]], and monitoring of the [[pathology]]. (18)F-FDG [[Positron emission tomography|PET]]/[[Computed tomography|CT]] may be helpful in the [[diagnosis]] of POEMS [[syndrome]]. Findings suggestive of POEMS [[syndrome]] include mixed [[bone]] [[Lesion|lesions]], [[lymphadenopathy]], [[hepatosplenomegaly]], and [[Serous membrane|serous cavity]] effusions. | (18)F-FDG [[Positron emission tomography|PET]]/[[Computed tomography|CT]] is an adequate tool for evaluation, [[diagnosis]], and monitoring of the [[pathology]]. (18)F-FDG [[Positron emission tomography|PET]]/[[Computed tomography|CT]] may be helpful in the [[diagnosis]] of POEMS [[syndrome]]. Findings suggestive of POEMS [[syndrome]] include mixed [[bone]] [[Lesion|lesions]], [[lymphadenopathy]], [[hepatosplenomegaly]], and [[Serous membrane|serous cavity]] effusions. Fluorescein angiography may reveal unilateral pooling of fluid consistent with cystoid macular edema. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
*(18)F-FDG [[Positron emission tomography|PET]]/[[Computed tomography|CT]] is an adequate tool for evaluation, [[diagnosis]], and monitoring of the [[pathology]].<ref name="pmid30713387">{{cite journal |vauthors=Infante JR, García L, Rayo JI, Serrano J, Moreno M, Cobo A, Jimenez P, Martínez A |title=Positron Emission Tomography-Computed Tomography in a Case of POEMS Syndrome |journal=Indian J Nucl Med |volume=34 |issue=1 |pages=66–68 |date=2019 |pmid=30713387 |doi=10.4103/ijnm.IJNM_120_18 |url=}}</ref> | *(18)F-FDG [[Positron emission tomography|PET]]/[[Computed tomography|CT]] is an adequate tool for evaluation, [[diagnosis]], and monitoring of the [[pathology]].<ref name="pmid30713387">{{cite journal |vauthors=Infante JR, García L, Rayo JI, Serrano J, Moreno M, Cobo A, Jimenez P, Martínez A |title=Positron Emission Tomography-Computed Tomography in a Case of POEMS Syndrome |journal=Indian J Nucl Med |volume=34 |issue=1 |pages=66–68 |date=2019 |pmid=30713387 |doi=10.4103/ijnm.IJNM_120_18 |url=}}</ref> | ||
| Line 12: | Line 12: | ||
**[[Splenomegaly]]<ref name="pmid26182964">{{cite journal |vauthors=Pan Q, Li J, Li F, Zhou D, Zhu Z |title=Characterizing POEMS Syndrome with 18F-FDG PET/CT |journal=J. Nucl. Med. |volume=56 |issue=9 |pages=1334–7 |date=September 2015 |pmid=26182964 |doi=10.2967/jnumed.115.160507 |url=}}</ref> | **[[Splenomegaly]]<ref name="pmid26182964">{{cite journal |vauthors=Pan Q, Li J, Li F, Zhou D, Zhu Z |title=Characterizing POEMS Syndrome with 18F-FDG PET/CT |journal=J. Nucl. Med. |volume=56 |issue=9 |pages=1334–7 |date=September 2015 |pmid=26182964 |doi=10.2967/jnumed.115.160507 |url=}}</ref> | ||
**[[Serous membrane|Serous cavity]] effusions<ref name="pmid26182964">{{cite journal |vauthors=Pan Q, Li J, Li F, Zhou D, Zhu Z |title=Characterizing POEMS Syndrome with 18F-FDG PET/CT |journal=J. Nucl. Med. |volume=56 |issue=9 |pages=1334–7 |date=September 2015 |pmid=26182964 |doi=10.2967/jnumed.115.160507 |url=}}</ref> | **[[Serous membrane|Serous cavity]] effusions<ref name="pmid26182964">{{cite journal |vauthors=Pan Q, Li J, Li F, Zhou D, Zhu Z |title=Characterizing POEMS Syndrome with 18F-FDG PET/CT |journal=J. Nucl. Med. |volume=56 |issue=9 |pages=1334–7 |date=September 2015 |pmid=26182964 |doi=10.2967/jnumed.115.160507 |url=}}</ref> | ||
*Fluorescein angiography may reveal unilateral pooling of fluid consistent with cystoid macular edema.<ref name="pmid19123170">{{cite journal |vauthors=Gutierrez-Ortiz C, Castro-Rebollo M, Pareja J, Beckford C, Teus M |title=Bilateral non-simultaneous optic neuropathy and unilateral macular edema in a patient with POEMS syndrome |journal=Eur J Ophthalmol |volume=19 |issue=1 |pages=166–9 |date=2009 |pmid=19123170 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 22:01, 6 February 2019
|
POEMS syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
POEMS syndrome other imaging findings On the Web |
|
American Roentgen Ray Society Images of POEMS syndrome other imaging findings |
|
Risk calculators and risk factors for POEMS syndrome other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
(18)F-FDG PET/CT is an adequate tool for evaluation, diagnosis, and monitoring of the pathology. (18)F-FDG PET/CT may be helpful in the diagnosis of POEMS syndrome. Findings suggestive of POEMS syndrome include mixed bone lesions, lymphadenopathy, hepatosplenomegaly, and serous cavity effusions. Fluorescein angiography may reveal unilateral pooling of fluid consistent with cystoid macular edema.
Other Imaging Findings
- (18)F-FDG PET/CT is an adequate tool for evaluation, diagnosis, and monitoring of the pathology.[1]
- (18)F-FDG PET/CT may be helpful in the diagnosis of POEMS syndrome. Findings suggestive of POEMS syndrome include:
- Mixed bone lesions (lytic and sclerotic)[2][1]
- Lymphadenopathy[2]
- Hepatomegaly[2]
- Splenomegaly[2]
- Serous cavity effusions[2]
- Fluorescein angiography may reveal unilateral pooling of fluid consistent with cystoid macular edema.[3]
References
- ↑ 1.0 1.1 Infante JR, García L, Rayo JI, Serrano J, Moreno M, Cobo A, Jimenez P, Martínez A (2019). "Positron Emission Tomography-Computed Tomography in a Case of POEMS Syndrome". Indian J Nucl Med. 34 (1): 66–68. doi:10.4103/ijnm.IJNM_120_18. PMID 30713387.
- ↑ 2.0 2.1 2.2 2.3 2.4 Pan Q, Li J, Li F, Zhou D, Zhu Z (September 2015). "Characterizing POEMS Syndrome with 18F-FDG PET/CT". J. Nucl. Med. 56 (9): 1334–7. doi:10.2967/jnumed.115.160507. PMID 26182964.
- ↑ Gutierrez-Ortiz C, Castro-Rebollo M, Pareja J, Beckford C, Teus M (2009). "Bilateral non-simultaneous optic neuropathy and unilateral macular edema in a patient with POEMS syndrome". Eur J Ophthalmol. 19 (1): 166–9. PMID 19123170.